Fox Chase Cancer Center Proudly Supports Pancreatic Cancer Action Network’s PurpleStride Philadelphia 2017

Purple Stride, Philadelphia 2017

PHILADELPHIA (October 4, 2017) – Fox Chase Cancer Center, a designated National Pancreatic Foundation Center, will again field a team of faculty, staff, patients, and friends to raise funds at the Pancreatic Cancer Action Network’s PurpleStride Philadelphia, the walk to end pancreatic cancer. This year the event is on Saturday, November 4 at Memorial Hall in Fairmount Park. Registration opens at 6 am and the 5K run/walk starts at 8 am. 

“At Fox Chase we take a multidisciplinary approach to pancreatic cancer diagnosis, treatment, and follow-up care, and to us that includes working together with our patients and friends in the community to raise funds for more research,” said Igor Astsaturov, MD, PhD, a medical oncologist at Fox Chase.

The Pancreatic Cancer Action Network has raised over $87 million for the cause through its community events from 2008 to 2016. The group is workin

For more information please visit foxchase.org/PurpleStride2017. To join the Fox Chase Cancer Center team, register online. 

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text